Canada's industry group proposes institute for demonstrating medtech value
This article was originally published in RAJ Devices
Canadian medical technology industry association MEDEC is proposing to develop an institute to demonstrate the economic value of medical technology in Canada1.
You may also be interested in...
The Therapeutic Goods Administration’s provisional approval for Gilead Sciences’ drug comes with a number of post-marketing obligations for the company.
Some reimbursement agencies in Europe have been misinterpreting Translarna’s label and stopping access to the drug for boys with Duchenne muscular dystrophy who have been taking it but whose disease has progressed, PTC says.
A European pilot project that lets drug companies developing innovative products receive scientific advice from two EU member states at the same time is proving its worth during the pandemic.